- Liver Abscess in Advanced Hepatocellular Carcinoma after Sorafenib Treatment
-
Shin SK, Jung YK, Yoon HH, Kwon OS, Kim YS, Choi DJ, Kim JH
- KMID: 1711306
- Korean J Gastroenterol.
- 2014 Jan;63(1):47-50.
- doi: 10.4166/kjg.2014.63.1.47
Hepatocellular carcinoma (HCC) is a critical global health issue and the third most common cause of cancer-related deaths worldwide. The majority of patients who present HCC are already at an... -
- CITED
-
- Close
- SHARE
-
- Close
- Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know
-
Braschi-Amirfarzan M, Tirumani S, Hodi FS, Nishino M
- KMID: 2468121
- Korean J Radiol.
- 2017 Feb;18(1):42-53.
- doi: 10.3348/kjr.2017.18.1.42
Over the past five years immune-checkpoint inhibitors have dramatically changed the therapeutic landscape of advanced solid and hematologic malignancies. The currently approved immune-checkpoint inhibitors include antibodies to cytotoxic T-lymphocyte antigen-4,... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Disseminated Intra-abdominal Gastrointestinal Stromal Tumor Managed with Low Dose Imatinib
-
Jang BH, Kim BW, Lim KJ, Kim BG, Park SM, Kim JS, Ji JS, Choi H
- KMID: 2373239
- Korean J Gastroenterol.
- 2015 Jun;65(6):366-369.
- doi: 10.4166/kjg.2015.65.6.366
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. Imatinib mesylate is recommended as adjuvant therapy for GIST after surgical resection. However, drug-related adverse events... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Pneumatosis Intestinalis Associated with Sunitinib Treatment for Renal Cell Carcinoma
-
Choi YA, Sim EH, Lee KE, Ko SY, Seo MJ, Yang YJ, Park JC, Park SY
- KMID: 1718068
- Korean J Gastroenterol.
- 2013 Jun;61(6):347-350.
- doi: 10.4166/kjg.2013.61.6.347
Sunitinib as a multitarget tyrosine kinase inhibitor is one of the anti-tumor agents, approved by the United States Food and Drug Administration to use treat gastrointestinal stromal tumor and metastatic... -
- CITED
-
- Close
- SHARE
-
- Close
- Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients
-
Lee SS, Jung SH, Ahn JS, Kim YK, Cho MS, Jung SY, Lee JJ, Kim HJ, Yang DH
- KMID: 2373738
- J Korean Med Sci.
- 2016 Jul;31(7):1160-1163.
- doi: 10.3346/jkms.2016.31.7.1160
Peripheral T cell lymphoma (PTCL) is a heterogeneous group of aggressive lymphomas with poor prognosis. Elderly (age ≥ 65years) patients generally have impaired bone marrow function, altered drug metabolism, comorbidities,... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma as first-line therapy
-
Oh MJ, Lee HJ, Lee SH
- KMID: 1705207
- Clin Mol Hepatol.
- 2013 Sep;19(3):288-299.
- doi: 10.3350/cmh.2013.19.3.288
BACKGROUND/AIMS: Hepatic arterial infusion chemotherapy (HAIC) with 5-fluorouracil and cisplatin for intractable advanced hepatocellular carcinoma (HCC) may have survival benefits. We aimed to determine the efficacy and safety of HAIC... -
- CITED
-
- Close
- SHARE
-
- Close
- A Meta-analysis of Chemotherapy related Cognitive Impairment in Patients with Breast Cancer
-
Park JH, Bae SH
- KMID: 1499492
- J Korean Acad Nurs.
- 2012 Oct;42(5):644-658.
- doi: 10.4040/jkan.2012.42.5.644
PURPOSE: The purpose of this study was to evaluate the cognitive effects of chemotherapy in patients with breast cancer. METHODS: Using several databases, prospective studies were collected up to August 2011.... -
- CITED
-
- Close
- SHARE
-
- Close
- Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer
-
Lee JH, Kim SH, Oh SY, Lee S, Lee H, Lee HJ, Kim HJ
- KMID: 1776453
- Korean J Intern Med.
- 2013 May;28(3):314-321.
- doi: 10.3904/kjim.2013.28.3.314
BACKGROUND/AIMS: To determine the efficacy and toxicity of docetaxel as a third-line therapy for patients with relapsed gastric cancer who have undergone modified oxaliplatin-fluorouracil (m-FOLFOX)-4 and modified irinotecan-fluorouracil (m-FOLFIRI) regimens. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
-
Yang H, Woo HY, Lee SK, Han JW, Jang B, Nam HC, Lee HL, Lee SW, Song DS, Song MJ, Oh JS, Chun HJ, Jang JW, Lozada A, Bae SH, Choi JY, Yoon SK
- KMID: 2413116
- Clin Mol Hepatol.
- 2017 Jun;23(2):128-137.
- doi: 10.3350/cmh.2016.0071
BACKGROUND/AIMS: Metronomic chemotherapy (MET) is frequently administered in comparatively low doses as a continuous chemotherapeutic agent. The aim of this study was to evaluate the feasibility and overall survival (OS)... -
- CITED
-
- Close
- SHARE
-
- Close
- A study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience
-
Oh MJ, Lee HJ
- KMID: 1493575
- Clin Mol Hepatol.
- 2013 Mar;19(1):51-59.
- doi: 10.3350/cmh.2013.19.1.51
BACKGROUND/AIMS: The widespread use of cytotoxic chemotherapy and immunosuppressants has resulted in reactivation of hepatitis B virus (HBV) recently becoming an issue. Although rituximab (an anti-CD20 monoclonal antibody) has revolutionized... -
- CITED
-
- Close
- SHARE
-
- Close
- Pancreatic Endocrine Tumors: A Report on a Patient Treated with Sorafenib
-
Jeong HK, Roh SY, Hong SH, Won HS, Jeon EK, Shin OR, Lee SL, Ko YH
- KMID: 1094270
- J Korean Med Sci.
- 2011 Jul;26(7):954-958.
- doi: 10.3346/jkms.2011.26.7.954
A 31-yr-old man with abdominal pain was diagnosed with a pancreatic endocrine tumor and multiple hepatic metastases. Despite optimal treatment with interferon alpha, a somatostatin analog, local therapy with high-intensity... -
- CITED
-
- Close
- SHARE
-
- Close
- Practical Effect of Sorafenib Monotherapy on Advanced Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis
-
Jeong SW, Jang JY, Shim KY, Lee SH, Kim SG, Cha SW, Kim YS, Cho YD, Kim HS, Kim BS, Kim KH, Kim JH
- KMID: 1712330
- Gut Liver.
- 2013 Nov;7(6):696-703.
BACKGROUND/AIMS: We investigated the effects of sorafenib monotherapy on advanced hepatocellular carcinoma (HCC) and portal vein tumor thrombosis (PVTT) in a clinical setting. METHODS: In total, 143 consecutive patients with unresectable... -
- CITED
-
- Close
- SHARE
-
- Close
- Late-onset Neutropenia Following Rituximab Therapy as a Treatment of Diffuse Large B-cell Lymphoma: A Single Institution Study
-
Kim M, Lee JK, Hong YJ, Hong SI, Kang HJ, Chang YH
- KMID: 1781661
- Korean J Lab Med.
- 2010 Dec;30(6):575-579.
- doi: 10.3343/kjlm.2010.30.6.575
BACKGROUND: Late-onset neutropenia (LON) following rituximab therapy has been reported in recent years. However, its incidence has not been reported in Korea. The aim of this study is to investigate... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Cabergoline as First Line Treatment for Invasive Giant Prolactinoma
-
Cho EH, Lee SA, Chung JY, Koh EH, Cho YH, Kim JH, Kim CJ, Kim MS
- KMID: 1782009
- J Korean Med Sci.
- 2009 Oct;24(5):874-878.
- doi: 10.3346/jkms.2009.24.5.874
Although cabergoline is effective in the treatment of micro- and macro-prolactinoma, little is known about its efficacy in the treatment of invasive giant prolactinoma. We investigated the efficacy and safety... -
- CITED
-
- Close
- SHARE
-
- Close
- The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea
-
Kim C, Lee HS, Min CK, Lee JJ, Kim K, Yoon DH, Eom HS, Lee H, Lee WS, Shin HJ, Lee JH, Park Y, Jo JC, Do YR, Mun YC
- KMID: 2381566
- Korean J Intern Med.
- 2015 Sep;30(5):675-683.
- doi: 10.3904/kjim.2015.30.5.675
BACKGROUND/AIMS: The purpose of this study was to determine the correlations between inflammatory factors-including absolute lymphocyte count, lactate dehydrogenase, beta2-microglobulin, albumin, C-reactive protein, and ferritin-and the prognosis for survival in... -
- CITED
-
- Close
- SHARE
-
- Close
